Taiwan
· Delayed Price · Currency is TWD Shine-On BioMedical Statistics
Total Valuation
TPEX:6926 has a market cap or net worth of TWD 3.28 billion. The enterprise value is 2.24 billion.
| Market Cap | 3.28B |
| Enterprise Value | 2.24B |
Important Dates
The next estimated earnings date is Friday, April 18, 2025.
| Earnings Date | Apr 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6926 has 49.80 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 49.80M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.55% |
| Owned by Institutions (%) | n/a |
| Float | 22.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.22 |
| P/TBV Ratio | 3.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.85 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -24.47 |
Financial Position
The company has a current ratio of 25.92, with a Debt / Equity ratio of 0.00.
| Current Ratio | 25.92 |
| Quick Ratio | 25.76 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -5,233.58 |
Financial Efficiency
Return on equity (ROE) is -11.04% and return on invested capital (ROIC) is -7.88%.
| Return on Equity (ROE) | -11.04% |
| Return on Assets (ROA) | -7.66% |
| Return on Invested Capital (ROIC) | -7.88% |
| Return on Capital Employed (ROCE) | -13.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.26M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.45% in the last 52 weeks. The beta is -0.09, so TPEX:6926's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -0.45% |
| 50-Day Moving Average | 66.10 |
| 200-Day Moving Average | 65.94 |
| Relative Strength Index (RSI) | 50.42 |
| Average Volume (20 Days) | 22,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -136.07M |
| Pretax Income | -118.59M |
| Net Income | -118.89M |
| EBITDA | -133.88M |
| EBIT | -136.07M |
| Earnings Per Share (EPS) | -2.39 |
Balance Sheet
The company has 1.04 billion in cash and 2.60 million in debt, giving a net cash position of 1.04 billion or 20.90 per share.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 2.60M |
| Net Cash | 1.04B |
| Net Cash Per Share | 20.90 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 20.48 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was -91.45 million and capital expenditures -110,000, giving a free cash flow of -91.56 million.
| Operating Cash Flow | -91.45M |
| Capital Expenditures | -110,000 |
| Free Cash Flow | -91.56M |
| FCF Per Share | -1.84 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6926 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | -0.39% |
| Earnings Yield | -3.62% |
| FCF Yield | -2.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |